Financhill
Back

Eli Lilly and 10K Form

Sell
48

LLY
Eli Lilly and

Last Price:
$757.94
Seasonality Move:
1.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LLY News And Ratings

See the #1 stock for the next 7 days that we like better than LLY

LLY Financial Statistics

Sales & Book Value

Annual Sales: $45B
Cash Flow: $-1.6B
Price / Cash Flow: 1732.74
Annual Sales: $17.56
Price / Book: 41.76

Profitability

EPS (TTM): 12.29000
Net Income (TTM): $11.1B
Gross Margin: $36.6B
Return on Equity: 78.25%
Return on Assets: 14.63%

Eli Lilly and Earnings Forecast

Key Eli Lilly and Financial Ratios

  • The Gross Profit Margin over the past 41 years for LLY is 81.31%.
  • The Selling, General & Administrative Expenses for LLY have been equal to 18.05% of Gross Profit Margin.
  • The Research & Development expenses have been 24.40% of Revenue.
  • The Interest Expense is 7.37% of Operating Income.
  • The Net Earning history of LLY is 23.51% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 24 years.

Eli Lilly and Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LLY
CUSIP: 532457
Website: lilly.com

Debt

Debt-to-Equity Ratio: 2.44
Current Ratio: 1.37
Quick Ratio: 0.57

Price-to-Earnings

Trailing P/E Ratio: 62.62
Forward P/E Ratio: 24.7

LLY Technical Analysis vs Fundamental Analysis

Sell
48
Eli Lilly and (LLY) is a Sell

Is Eli Lilly and a Buy or a Sell?

  • Eli Lilly and stock is rated a Sell
    The current Eli Lilly and [LLY] share price is $733.29. The Score for LLY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.